Focus Stock of the Week: Why JP Morgan Chase & Co. is a Strong Buy

SP Capital IQ |

S&P Capital IQ Equity Analyst Erik Oja has a 5-STARS  "Strong Buy" recommendation for JP Morgan Chase & Co.  For more information, please visit:  www.marketscope.com.   



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
JPM JP Morgan Chase 90.33 -0.80 -0.88 15,062,298
ATUAF Aeon Thana Sinsap Fgn Reg n/a n/a n/a 0

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…